Rieflin William Jlinsider trades

In SEC Form 4 filings, Rieflin William Jl is listed as Director of Lycia Therapeutics, Inc. (LYCA). Rieflin William Jl reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 26.

Companies and roles

Company	Role	Transactions	Last filed
LYCALycia Therapeutics, Inc.	Director	2	Oct 26

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-26

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
LYCALycia Therapeutics, Inc.	Oct 22	Oct 26	A · derivative	20,000	$18.00	$360,000	20,000	No	Form 4
LYCALycia Therapeutics, Inc.	Aug 11	Oct 26	A · derivative	24,840	$3.70	$91,908	24,840	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.